Your browser doesn't support javascript.
loading
Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
Bidulka, Patrick; Mathur, Rohini; Lugo-Palacios, David G; O'Neill, Stephen; Basu, Anirban; Silverwood, Richard J; Charlton, Paul; Briggs, Andrew; Smeeth, Liam; Adler, Amanda I; Douglas, Ian J; Khunti, Kamlesh; Grieve, Richard.
Afiliación
  • Bidulka P; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Mathur R; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Lugo-Palacios DG; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
  • O'Neill S; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
  • Basu A; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle, Washington.
  • Silverwood RJ; Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.
  • Charlton P; Patient Research Champion Team, National Institute for Health Research, Twickenham, UK.
  • Briggs A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
  • Smeeth L; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Adler AI; Diabetes Trials Unit, The Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Headington, UK.
  • Douglas IJ; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Grieve R; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Diabetes Obes Metab ; 25(1): 282-292, 2023 01.
Article en En | MEDLINE | ID: mdl-36134467
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Equity_inequality Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Equity_inequality Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido